KR20200134175A - 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염 - Google Patents

신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염 Download PDF

Info

Publication number
KR20200134175A
KR20200134175A KR1020200060397A KR20200060397A KR20200134175A KR 20200134175 A KR20200134175 A KR 20200134175A KR 1020200060397 A KR1020200060397 A KR 1020200060397A KR 20200060397 A KR20200060397 A KR 20200060397A KR 20200134175 A KR20200134175 A KR 20200134175A
Authority
KR
South Korea
Prior art keywords
substituted
unsubstituted
gly
leu
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020200060397A
Other languages
English (en)
Korean (ko)
Inventor
김유석
김명환
김영인
임택주
임형준
김지영
박은영
Original Assignee
주식회사 아이바이오코리아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 아이바이오코리아 filed Critical 주식회사 아이바이오코리아
Publication of KR20200134175A publication Critical patent/KR20200134175A/ko
Priority to KR1020220053844A priority Critical patent/KR102523943B1/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/55—Peptide, protein hydrolysate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
KR1020200060397A 2019-05-21 2020-05-20 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염 Ceased KR20200134175A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020220053844A KR102523943B1 (ko) 2019-05-21 2022-04-29 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190059628 2019-05-21
KR20190059628 2019-05-21

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020220053844A Division KR102523943B1 (ko) 2019-05-21 2022-04-29 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염

Publications (1)

Publication Number Publication Date
KR20200134175A true KR20200134175A (ko) 2020-12-01

Family

ID=73458705

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020200060397A Ceased KR20200134175A (ko) 2019-05-21 2020-05-20 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염
KR1020220053844A Active KR102523943B1 (ko) 2019-05-21 2022-04-29 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020220053844A Active KR102523943B1 (ko) 2019-05-21 2022-04-29 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염

Country Status (15)

Country Link
US (2) US12428446B2 (https=)
EP (2) EP3974441B1 (https=)
JP (1) JP7576048B2 (https=)
KR (2) KR20200134175A (https=)
CN (1) CN114269769B (https=)
AU (1) AU2020277930B2 (https=)
BR (1) BR112021023477A2 (https=)
CA (1) CA3139411A1 (https=)
ES (1) ES3012499T3 (https=)
MX (1) MX2021014051A (https=)
MY (1) MY205382A (https=)
PL (1) PL3974441T3 (https=)
SG (1) SG11202112276RA (https=)
WO (1) WO2020235932A1 (https=)
ZA (1) ZA202109175B (https=)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220062252A (ko) * 2019-05-21 2022-05-16 주식회사 아이바이오코리아 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염
KR20230090224A (ko) * 2021-12-13 2023-06-21 주식회사 아이바이오코리아 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물
KR20230089987A (ko) 2021-12-14 2023-06-21 주식회사 아이바이오코리아 펩타이드 약물을 포함하는 안구 투여용 약학 조성물
WO2023113300A1 (ko) * 2021-12-13 2023-06-22 주식회사 아이바이오코리아 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물
KR102587729B1 (ko) 2023-02-27 2023-10-12 주식회사 아이바이오코리아 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023224454A1 (ko) 2022-05-20 2023-11-23 주식회사 엘지화학 양극 활물질 및 이의 제조방법
KR102728422B1 (ko) * 2024-05-27 2024-11-11 주식회사 아이바이오코리아 염증성 질환의 치료 효과를 갖는 신규한 펩타이드 및 이의 용도

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084555A (en) 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
IT1241761B (it) * 1990-08-03 1994-02-01 Menarini Farma Ind Peptidi di sintesi antagonisti della neurochinina a, loro sali e relativi procedimenti di fabbricazione
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
WO2004074312A2 (en) * 2003-02-05 2004-09-02 University Of Ulster Tryptophyllin peptides and uses thereof
NZ577196A (en) 2005-01-20 2011-06-30 Biomarck Pharmaceuticals Ltd Mucin hypersecretion inhibitors based on the structure of MANS and methods of use
US8378070B2 (en) 2007-03-12 2013-02-19 Ramot At Tel-Aviv University Ltd. Peptides for the regulation of neurotransmitter sequestration and release
AU2008297541A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
US20090074672A1 (en) 2007-09-17 2009-03-19 Sri International Tumor Boundary Imaging
JP5299956B2 (ja) 2008-09-29 2013-09-25 国立大学法人東北大学 質量分析装置を用いた代謝酵素群の一斉タンパク質定量に用いるペプチド
WO2011060349A1 (en) 2009-11-13 2011-05-19 North Carolina State University Methods of modulating mesenchymal stem cells
CA2869599C (en) * 2012-04-13 2021-07-27 Lubrizol Advanced Materials, Inc. Compounds which inhibit neuronal exocytosis (ii)
WO2013158230A1 (en) 2012-04-19 2013-10-24 The Regents Of The University Of California Compositions and methods for detecting unstable arteriosclerotic plaques
KR101438744B1 (ko) 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
KR101721059B1 (ko) 2014-12-26 2017-03-30 주식회사 아이바이오코리아 안구 표면 질환 예방 또는 치료용 약학조성물
KR101810163B1 (ko) 2016-04-08 2018-01-25 주식회사 아이바이오코리아 안구 표면질환 예방 또는 치료용 약학조성물
KR101798183B1 (ko) * 2016-04-08 2017-11-15 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
EP3539559B1 (en) 2016-04-08 2020-08-26 Eyebio Korea Collagen type ii alpha-1-based peptide for use in the treatment of macular degeneration
KR101795650B1 (ko) 2016-05-12 2017-11-09 인제대학교 산학협력단 아플리버셉트-콜라겐 타입 ii 펩타이드의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
KR101795653B1 (ko) 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
JP2019524673A (ja) * 2016-06-28 2019-09-05 バロリゼーション−ルシェルシュ，リミテッド パートナーシップ 新規な環状ペプチドおよびその使用
HUP1700012A2 (en) * 2017-01-06 2018-07-30 Evolveritas Kft Novel proteins and use thereof
EP3609519B1 (en) * 2017-04-11 2025-11-26 University of Maryland, Baltimore Compositions and methods for treating inflammation and cancer
RU2766160C2 (ru) * 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента
CN107814840B (zh) * 2017-12-12 2020-04-10 浙江辉肽生命健康科技有限公司 一种生物活性多肽pkypvepf及其制备方法和应用
CN108727472A (zh) * 2018-06-07 2018-11-02 南方医科大学 带负电荷的细胞穿透肽及作为细胞内运送载体的用途
TWI865470B (zh) 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
BR112021023477A2 (pt) 2019-05-21 2022-02-15 Eyebio Korea Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220062252A (ko) * 2019-05-21 2022-05-16 주식회사 아이바이오코리아 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염
US12428446B2 (en) 2019-05-21 2025-09-30 Eyebio Korea Peptide compound or pharmaceutically acceptable salt thereof
KR20230090224A (ko) * 2021-12-13 2023-06-21 주식회사 아이바이오코리아 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물
WO2023113300A1 (ko) * 2021-12-13 2023-06-22 주식회사 아이바이오코리아 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물
KR20230089987A (ko) 2021-12-14 2023-06-21 주식회사 아이바이오코리아 펩타이드 약물을 포함하는 안구 투여용 약학 조성물
KR102587729B1 (ko) 2023-02-27 2023-10-12 주식회사 아이바이오코리아 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물
WO2024181833A1 (ko) 2023-02-27 2024-09-06 주식회사 아이바이오코리아 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물
EP4674425A1 (en) 2023-02-27 2026-01-07 EyebioKorea, Inc. Composition for treating diabetic retinopathy, comprising peptide

Also Published As

Publication number Publication date
JP7576048B2 (ja) 2024-10-30
EP4483959A3 (en) 2025-06-04
EP4483959A2 (en) 2025-01-01
SG11202112276RA (en) 2021-12-30
KR102523943B1 (ko) 2023-04-20
CN114269769B (zh) 2024-12-06
EP3974441A1 (en) 2022-03-30
PL3974441T3 (pl) 2025-04-07
EP3974441B1 (en) 2024-12-04
EP3974441A4 (en) 2023-10-18
CA3139411A1 (en) 2020-11-26
ES3012499T3 (en) 2025-04-09
ZA202109175B (en) 2024-04-24
WO2020235932A1 (ko) 2020-11-26
BR112021023477A2 (pt) 2022-02-15
US20240228538A1 (en) 2024-07-11
KR20220062252A (ko) 2022-05-16
US12428446B2 (en) 2025-09-30
JP2022533991A (ja) 2022-07-27
MX2021014051A (es) 2022-02-11
AU2020277930B2 (en) 2024-06-13
CN114269769A (zh) 2022-04-01
US20240352071A1 (en) 2024-10-24
MY205382A (en) 2024-10-18
AU2020277930A1 (en) 2021-12-09

Similar Documents

Publication Publication Date Title
KR102523943B1 (ko) 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염
KR101734064B1 (ko) 마이시니딘 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
KR101957014B1 (ko) 항염증 활성을 나타내는 펩타이드 및 이를 유효성분으로 포함하는 항염증용 조성물
KR101595440B1 (ko) Ｃｍ－ｍａ 펩타이드로부터 유래된 유사체 펩타이드 ｃｍａ３ 및 이의 용도
KR101980897B1 (ko) Ll37 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
KR102158036B1 (ko) Pseudin-2 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
KR102353335B1 (ko) 무궁화 에탄올 추출물의 분획물을 포함하는 tlr4-md2 저해제 조성물
KR102032945B1 (ko) 항염증 활성을 나타내는 펩타이드 및 이를 유효성분으로 포함하는 항염증용 조성물
KR102603281B1 (ko) Hylin a1 펩타이드로부터 유래한 신규 펩타이드 및 이의 용도
RU2824612C2 (ru) Новое пептидное соединение или его фармацевтически приемлемая соль
KR20200134153A (ko) 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염
KR102039400B1 (ko) mBjAMP1 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
KR101998106B1 (ko) Hp1404 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
KR102725513B1 (ko) 항염증 효능을 가지는 곤충유래 프로테티아마이신-9 펩타이드 및 이의 용도
HK40068628A (en) Novel peptide compound or pharmaceutically acceptable salt thereof
KR101930125B1 (ko) 스테이플화된 헵타펩타이드 및 이의 용도
HK40068628B (zh) 新型肽化合物或其药学上可接受的盐
KR101713143B1 (ko) 클라바스피린 펩타이드 유사체를 유효성분으로 함유하는 항염증용 조성물
KR102608336B1 (ko) Pep27 펩타이드로부터 유래한 신규 펩타이드 및 이의 용도
KR20240128192A (ko) 항염증 펩타이드 pn5를 포함하는 염증성 질환의 예방 또는 치료용 조성물
KR20230040784A (ko) 항염증 효능을 가지는 곤충유래 프로테티아마이신-11 펩타이드 및 이의 용도
JP2023044235A (ja) イムノグロブリンａ産生促進用組成物

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A302 Request for accelerated examination
PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PE0801 Dismissal of amendment

St.27 status event code: A-2-2-P10-P12-nap-PE0801

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

X091 Application refused [patent]
T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0601 Decision of rejection after re-examination

St.27 status event code: N-2-6-B10-B17-rex-PX0601

X601 Decision of rejection after re-examination
A107 Divisional application of patent
J201 Request for trial against refusal decision
PA0107 Divisional application

St.27 status event code: A-0-1-A10-A18-div-PA0107

St.27 status event code: A-0-1-A10-A16-div-PA0107

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

J301 Trial decision

Free format text: TRIAL NUMBER: 2022101001008; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20220429

Effective date: 20221031

PJ1301 Trial decision

St.27 status event code: A-3-3-V10-V15-crt-PJ1301

Decision date: 20221031

Appeal event data comment text: Appeal Kind Category : Appeal against decision to decline refusal, Appeal Ground Text : 2020 0060397

Appeal request date: 20220429

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2022101001008

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

R13 Change to the name of applicant or owner recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R13-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)